Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014’, provides an overview of the Asklepios BioPharmaceutical, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Asklepios BioPharmaceutical, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are... Research Beam Model: Research Beam Product ID: 152276 1500 USD New
Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014
 
 

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

  • Category : Pharmaceuticals
  • Published On : October   2014
  • Pages : 27
  • Publisher : Global Markets Direct
 
 
 
Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014’, provides an overview of the Asklepios BioPharmaceutical, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Asklepios BioPharmaceutical, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Asklepios BioPharmaceutical, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Asklepios BioPharmaceutical, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Asklepios BioPharmaceutical, Inc.’s pipeline products

Reasons to buy

- Evaluate Asklepios BioPharmaceutical, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Asklepios BioPharmaceutical, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Asklepios BioPharmaceutical, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Asklepios BioPharmaceutical, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Asklepios BioPharmaceutical, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Asklepios BioPharmaceutical, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Asklepios BioPharmaceutical, Inc. Snapshot 5
Asklepios BioPharmaceutical, Inc. Overview 5
Key Information 5
Key Facts 5
Asklepios BioPharmaceutical, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Asklepios BioPharmaceutical, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Asklepios BioPharmaceutical, Inc. - Pipeline Products Glance 10
Asklepios BioPharmaceutical, Inc. - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Asklepios BioPharmaceutical, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Asklepios BioPharmaceutical, Inc. - Drug Profiles 13
AskBio-009 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Biostrophin 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
BNP-CHF 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
BNP-TLE 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
BNP-OA 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
BNP-RP 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Asklepios BioPharmaceutical, Inc. - Pipeline Analysis 19
Asklepios BioPharmaceutical, Inc. - Pipeline Products by Target 19
Asklepios BioPharmaceutical, Inc. - Pipeline Products by Route of Administration 20
Asklepios BioPharmaceutical, Inc. - Pipeline Products by Molecule Type 21
Asklepios BioPharmaceutical, Inc. - Pipeline Products by Mechanism of Action 22
Asklepios BioPharmaceutical, Inc. - Recent Pipeline Updates 23
Asklepios BioPharmaceutical, Inc. - Dormant Projects 24
Asklepios BioPharmaceutical, Inc. - Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27
List Of Tables
List of Tables
Asklepios BioPharmaceutical, Inc., Key Information 5
Asklepios BioPharmaceutical, Inc., Key Facts 5
Asklepios BioPharmaceutical, Inc. - Pipeline by Indication, 2014 7
Asklepios BioPharmaceutical, Inc. - Pipeline by Stage of Development, 2014 8
Asklepios BioPharmaceutical, Inc. - Monotherapy Products in Pipeline, 2014 9
Asklepios BioPharmaceutical, Inc. - Phase I, 2014 10
Asklepios BioPharmaceutical, Inc. - Preclinical, 2014 11
Asklepios BioPharmaceutical, Inc. - Discovery, 2014 12
Asklepios BioPharmaceutical, Inc. - Pipeline by Target, 2014 19
Asklepios BioPharmaceutical, Inc. - Pipeline by Route of Administration, 2014 20
Asklepios BioPharmaceutical, Inc. - Pipeline by Molecule Type, 2014 21
Asklepios BioPharmaceutical, Inc. - Pipeline Products by Mechanism of Action, 2014 22
Asklepios BioPharmaceutical, Inc. - Recent Pipeline Updates, 2014 23
Asklepios BioPharmaceutical, Inc. - Dormant Developmental Projects,2014 24
List Of Figures
List of Figures
Asklepios BioPharmaceutical, Inc. - Pipeline by Top 10 Indication, 2014 7
Asklepios BioPharmaceutical, Inc. - Pipeline by Stage of Development, 2014 8
Asklepios BioPharmaceutical, Inc. - Monotherapy Products in Pipeline, 2014 9
Asklepios BioPharmaceutical, Inc. - Pipeline by Top 10 Target, 2014 19
Asklepios BioPharmaceutical, Inc. - Pipeline by Top 10 Route of Administration, 2014 20
Asklepios BioPharmaceutical, Inc. - Pipeline by Top 10 Molecule Type, 2014 21
Asklepios BioPharmaceutical, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 22
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT